Achim Wöckel

6.1k total citations
245 papers, 3.3k citations indexed

About

Achim Wöckel is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Achim Wöckel has authored 245 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Oncology, 94 papers in Cancer Research and 61 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Achim Wöckel's work include Breast Cancer Treatment Studies (90 papers), Advanced Breast Cancer Therapies (44 papers) and HER2/EGFR in Cancer Research (28 papers). Achim Wöckel is often cited by papers focused on Breast Cancer Treatment Studies (90 papers), Advanced Breast Cancer Therapies (44 papers) and HER2/EGFR in Cancer Research (28 papers). Achim Wöckel collaborates with scholars based in Germany, United States and Switzerland. Achim Wöckel's co-authors include R. Kreienberg, Lukas Schwentner, Manfred Wischnewsky, Wolfgang Janni, Maria Blettner, Michael Abou‐Dakn, Tanja Stüber, R. Wolters, Ina Monsef and Nicole Skoetz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Achim Wöckel

224 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Achim Wöckel Germany 32 1.3k 921 448 436 411 245 3.3k
Kirstin Pirie United Kingdom 25 1.2k 1.0× 400 0.4× 526 1.2× 302 0.7× 457 1.1× 36 3.1k
Sjoerd G. Elias Netherlands 43 1.7k 1.3× 504 0.5× 484 1.1× 1.0k 2.4× 617 1.5× 159 4.9k
Anna K.L. Reyners Netherlands 29 1.0k 0.8× 346 0.4× 313 0.7× 657 1.5× 582 1.4× 129 2.5k
Shirong Cai China 39 1.3k 1.0× 659 0.7× 488 1.1× 1.0k 2.3× 1.2k 2.9× 171 4.6k
David R. Doody United States 31 1.2k 0.9× 719 0.8× 305 0.7× 356 0.8× 1.1k 2.7× 85 3.4k
Amanda I. Phipps United States 36 2.6k 2.0× 1.1k 1.2× 334 0.7× 683 1.6× 802 2.0× 141 4.3k
Diana L. Urbauer United States 39 1.5k 1.2× 683 0.7× 603 1.3× 736 1.7× 843 2.1× 150 4.9k
Marian J.E. Mourits Netherlands 38 1.3k 1.0× 681 0.7× 376 0.8× 234 0.5× 456 1.1× 139 4.6k
Bryan Fellman United States 29 955 0.7× 320 0.3× 210 0.5× 595 1.4× 477 1.2× 188 2.8k
Adnan Aydıner Türkiye 25 1.0k 0.8× 295 0.3× 185 0.4× 473 1.1× 304 0.7× 156 2.3k

Countries citing papers authored by Achim Wöckel

Since Specialization
Citations

This map shows the geographic impact of Achim Wöckel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Achim Wöckel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Achim Wöckel more than expected).

Fields of papers citing papers by Achim Wöckel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Achim Wöckel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Achim Wöckel. The network helps show where Achim Wöckel may publish in the future.

Co-authorship network of co-authors of Achim Wöckel

This figure shows the co-authorship network connecting the top 25 collaborators of Achim Wöckel. A scholar is included among the top collaborators of Achim Wöckel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Achim Wöckel. Achim Wöckel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kautz‐Freimuth, Sibylle, Anke Steckelberg, Frank Vitinius, et al.. (2025). Factors influencing role preferences in decision-making of healthy women with BRCA1/2 pathogenic variants: subanalysis from a randomised controlled decision coaching trial. BMC Cancer. 25(1). 164–164. 1 indexed citations
2.
Sauer, Stephanie, et al.. (2024). Evaluating the value of individualized 3D printed models for examination, diagnosis and treatment planning of cervical cancer. SHILAP Revista de lepidopterología. 10(1). 25–25.
3.
Wöckel, Achim, et al.. (2024). Assessment of psychological distress in patients with cervical dysplasia according to age, education, information acquisition and information level. Archives of Gynecology and Obstetrics. 310(4). 2173–2181. 1 indexed citations
4.
Thill, Marc, Anja Welt, Arnd Nusch, et al.. (2024). Head‐to‐head comparison of palbociclib and ribociclib in first‐line treatment of HR‐positive/HER2‐negative metastatic breast cancer with real‐world data from the OPAL registry. International Journal of Cancer. 156(9). 1770–1782. 5 indexed citations
5.
Wöckel, Achim, et al.. (2024). High-throughput drug screening to investigate blood-brain barrier permeability in vitro with a focus on breast cancer chemotherapeutic agents. SHILAP Revista de lepidopterología. 4. 1331126–1331126. 1 indexed citations
6.
Vilsmaier, Theresa�, et al.. (2023). POSTER 17The cytokines IL-1b and IL-18 are upregulated in the placenta of recurrent miscarriage patients. Journal of Reproductive Immunology. 158. 103600–103600. 1 indexed citations
7.
8.
Flock, Felix, R. Felberbaum, Wolfgang Janni, et al.. (2023). Predictors of Decreased Quality of Life in Breast Cancer Survivors Five Years After Diagnosis. Journal of Breast Cancer. 26(3). 243–243. 3 indexed citations
10.
Wulff, Christine, et al.. (2023). Diagnostik und Therapie des Vulva- und des Vaginalkarzinoms. 29(5). 457–464.
11.
Abou‐Dakn, Michael, Ute Alexy, Kirsten Beyer, et al.. (2022). Ernährung und Bewegung im Kleinkindalter. Monatsschrift Kinderheilkunde. 171(S1). 7–27. 3 indexed citations
12.
Herr, Daniel, Manfred Wischnewsky, Wolfgang Janni, et al.. (2019). Does chemotherapy improve survival in patients with nodal positive luminal A breast cancer? A retrospective Multicenter Study. PLoS ONE. 14(7). e0218434–e0218434. 21 indexed citations
13.
Lebeau, Annette, Carsten Denkert, Hans‐Peter Sinn, Marcus Schmidt, & Achim Wöckel. (2019). Update der S3-Leitlinie Mammakarzinom: Was gibt es Neues für Pathologen?. Der Pathologe. 40(2). 185–198. 1 indexed citations
14.
Ebner, Florian, Achim Wöckel, Lukas Schwentner, et al.. (2019). Does the number of removed axillary lymphnodes in high risk breast cancer patients influence the survival?. BMC Cancer. 19(1). 90–90. 9 indexed citations
17.
Wöckel, Achim, et al.. (2016). Challenges of Longevity: Safety of Vaginal and Laparoscopic Urogynecological Procedures in Septuagenarians and Older Patients. BioMed Research International. 2016. 1–9. 7 indexed citations
18.
Ebner, Florian, et al.. (2014). Should a Drain Be Placed in Early Breast Cancer Surgery?. Breast Care. 9(2). 116–116. 7 indexed citations
19.
Hancke, Katharina, Michael Denkinger, J. König, et al.. (2009). Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study. Annals of Oncology. 21(4). 748–753. 83 indexed citations
20.
Wöckel, Achim, et al.. (2005). Constitutive Coexpression of Nitric Oxide Synthase-1 and Soluble Guanylyl Cyclase in Myoepithelial Cells of Mammary Glands in Mice. Cells Tissues Organs. 180(3). 178–184. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026